Literature DB >> 18274938

Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration.

Zheng Cai1, Shixiang Hou, Yuanbo Li, Binbin Zhao, Zhaoxiang Yang, Shuguang Xu, Junxue Pu.   

Abstract

Both borneol and gastrodin are bioactive substances derived from traditional Chinese medicine. In this paper, the effect of borneol on the distribution of gastrodin to the brain in mice via oral administration was investigated. Gastrodin concentrations in plasma and gastrodigenin (active metabolite of gastrodin) concentrations in the brain of mice were determined by reversed-phase high-performance liquid chromatography, after intragastric administration of gastrodin (200 mg kg(-1)) alone or combined with different doses (200, 400 and 600 mg kg(-1)) of borneol simultaneously or the same dose (400 mg kg(-1)) of borneol given 20 and 40 min beforehand, respectively. Compared with the administration of gastrodin alone, gastrodin coadministrated with borneol could have been rapidly absorbed from the gastrointestinal tract; the peak time of gastrodin in the plasma became shorter (5-15 vs. 30 min); the bioavailability of gastrodigenin in the brain was increased by 33.6-108.8%; and obvious brain-targeting effect was observed. The enhancing effect was attenuated when the dose of borneol was too high (600 mg kg(-1)), or the time interval between the administration of borneol and gastrodin was longer than 40 min. The results indicate that borneol can accelerate the absorption of gastrodin in the gastrointestinal tract and promote its distribution to the brain. Therefore, borneol is a promising promoter for oral brain-targeting drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274938     DOI: 10.1080/10611860701794395

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  32 in total

Review 1.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

2.  The pharmacokinetics of Tiangou antihypertensive capsule in rat in vivo.

Authors:  Ji-Zheng Song; Ling-Jun Li; Li Ji; Li Shun; Yan Rui
Journal:  Biomed Rep       Date:  2016-11-15

3.  Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.

Authors:  Chun Wu; Qiongfeng Liao; Meicun Yao; Xinjun Xu; Yuting Zhou; Xueying Hou; Zhiyong Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

4.  Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris.

Authors:  Sha Liao; Liwen Han; Xiaopu Zheng; Xin Wang; Peng Zhang; Jingni Wu; Ruimin Liu; Youlan Fu; Jiaxin Sun; Ximeng Kang; Kechun Liu; Tai-Ping Fan; Shao Li; Xiaohui Zheng
Journal:  Br J Pharmacol       Date:  2019-07-09       Impact factor: 8.739

5.  Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats.

Authors:  Noha Nafee; Abd El Rahman Ameen; Osama Y Abdallah
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

6.  Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats.

Authors:  Pan Xu; Ying Li; Shou-ying Du; Yang Lu; Jie Bai; Qing-li Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

7.  Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration.

Authors:  Yang Lu; Shou-ying Du; Xiao-lan Chen; Qing Wu; Xiao Song; Bing Xu; Yong-song Zhai
Journal:  J Zhejiang Univ Sci B       Date:  2011-02       Impact factor: 3.066

8.  Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.

Authors:  Zheng Cai; Xiangrong Song; Feng Sun; Zhaoxiang Yang; Shixiang Hou; Zhongqiu Liu
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

9.  Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations.

Authors:  Jing-yi Zhao; Yang Lu; Shou-ying Du; Xiao Song; Jie Bai; Yue Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

10.  The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.

Authors:  Lin Zhang; Limei Han; Jing Qin; Weiyue Lu; Jianxin Wang
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.